Young David Insider Trading Activity
Young David has been net-buying over the last 12 months with 6 purchases and 0 sales across 1 company.
PCSA is the most-traded position with 6 trades. The largest single transaction was a purchase of PCSA for $5K on Jun 30, 2026.
Performance Scorecard
Forward stock performance after each transaction by Young David. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | -7.1% | — | 40% | 5 |
| 90 days | -23.5% | — | 0% | 1 |
| 120 days | — | — | — | — |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPCSA · Processa Pharmaceuticals, Inc.
🔒 Subscribe to see trade entries
Pro members see exactly when Young David bought and sold PCSA.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
Jun 30, 2026 | PCSA | Buy | 2,531 | $1.93 | $5K | +13.2% | Pres. Research & Development | |
May 29, 2026 | PCSA | Buy | 1,786 | $2.57 | $5K | +11.6% | Pres. Research & Development | |
May 15, 2026 | PCSA | Buy | 1,545 | $2.97 | $5K | +11.2% | Pres. Research & Development | |
Apr 30, 2026 | PCSA | Buy | 1,706 | $2.69 | $5K | +14.1% | Pres. Research & Development | |
Apr 15, 2026 | PCSA | Buy | 1,545 | $2.97 | $5K | +14.6% | Pres. Research & Development | |
Mar 31, 2026 | PCSA | Buy | 1,810 | $2.54 | $5K | +20.7% | Pres. Research & Development |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PCSA | Processa Pharmaceuticals, Inc. | 6 | $28K |
Other insiders at Processa Pharmaceuticals, Inc.
5 other tracked filers at PCSA.